GenScript’s new facility is set to improve support for scientists in the Asia-Pacific region with shorter delivery time and local collaboration.
Malaysia has granted a conditional registration for an affordable hepatitis C treatment developed through public-private partnerships with organizations in Egypt and Thailand.
reSET is a 12-week prescription treatment for substance use disorder.
Singapore's Health Sciences Authority has granted conditional approval of remdesivir as a treatment for patients with severe COVID-19.
Lucence has developed a kit that can stabilize COVID-19 test samples and is making 10,000 of the kits freely available to the scientific community.